AU768399B2 - Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use - Google Patents

Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use Download PDF

Info

Publication number
AU768399B2
AU768399B2 AU39611/00A AU3961100A AU768399B2 AU 768399 B2 AU768399 B2 AU 768399B2 AU 39611/00 A AU39611/00 A AU 39611/00A AU 3961100 A AU3961100 A AU 3961100A AU 768399 B2 AU768399 B2 AU 768399B2
Authority
AU
Australia
Prior art keywords
micromixer
communicating channel
mixed
preparation
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU39611/00A
Other versions
AU3961100A (en
Inventor
Joachim Bunger
Hans-Jurgen Driller
Annette Wagner
Jutta Zur Lage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU3961100A publication Critical patent/AU3961100A/en
Application granted granted Critical
Publication of AU768399B2 publication Critical patent/AU768399B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/068Microemulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/066Multiple emulsions, e.g. water-in-oil-in-water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/21Mixing of ingredients for cosmetic or perfume compositions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22Mixing of ingredients for pharmaceutical or medical compositions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40Mixing liquids with liquids; Emulsifying
    • B01F23/41Emulsifying

Description

2001 9911777.doc 1/22 -1- Process for the preparation of cosmetic or pharmaceutical formulations using a micromixer The present invention relates to a process for the preparation of cosmetic or pharmaceutical formulations immediately before use, in which two or more liquid components from separate stock chambers are mixed intimately with one another by passing the liquid components through a micromixer. The present invention furthermore relates to the lotions, emulsions, gels, creams and solutions prepared by the process according to the invention, either for cosmetic use or, if corresponding pharmaceutical active ingredients have been incorporated, to the pharmaceutical formulations prepared.
15 Various processes for mixing a plurality of substances as intimately as possible are used for the preparation of cosmetic products. Depending on the mixing intensity necessary, use is made of one or more processes for combining substances, which can take place successively or in parallel.
In chemical process technology, the term mixing is taken to mean per se basic operations which serve for very substantial homogenisation of substances. The aim is to combine substance streams in such a way that the most uniform composition possible of the individual components is obtained in part-volumes of the resultant mixture.
A special form of mixing is homogenisation. This is taken to mean mixing of phases which are immiscible with one another. Accordingly, the term homogenisation is taken to mean a change in the state of distribution and the particle size of the internal phase of emulsions and suspensions, so that, in microscopic terms, a homogenous system is formed and the distributed phase does not settle out or cream up without the action of external forces.
The term dispersion is taken to mean mixing of a substance system consisting of two (or more) phases, in which one substance (disperse phases) is distributed (dispersed) in extremely fine form in another substance (dispersion medium). Both the particles of the disperse phase 2001 9911777.doc 2/22 -2and the dispersion medium may be solid, liquid or gaseous. Examples of dispersions are aerosols, emulsions, suspensions and colloids.
Another type of mixing which is conventional in the preparation of cosmetics is emulsification. This is taken to mean mixing of two liquids which are insoluble or only sparingly soluble in one another and of which one is finely distributed in the other. The external phase is referred to as the continuous phase or dispersion medium, and the liquid distributed therein is referred to as the internal, discontinuous or disperse phase.
Cosmetic emulsions usually consist of an aqueous polar phase and a nonpolar oil phase.
The term suspension on the other hand is taken to mean the distribution of very small, but not molecular particles of a solid in a liquid. Suspensions, like emulsions, are usually optically cloudy and tend to settle out under the influence of gravity.
Emulsification processes are usually carried out in accordance with the following scheme: two substances which are insoluble in one another, namely fat and water, are mixed. In order to obtain a durable emulsion, the fat and water phases must be comminuted mechanically to less than pm and subsequently stabilised with the aid of an emulsifier. The oil and fat phase are normally initially introduced separately, warmed to 0 C and subsequently pre-emulsified. All water-soluble substances are located in the water phase, and all fat-soluble substances in the fat phase.
The pre-emulsion prepared by the hot/hot process (both phases are warmed separately to 50-70 0 C) is cooled to room temperature before addition of perfume oil and dye and is subsequently post-emulsified.
Some cases of emulsion preparation can start from a water phase at 20 30 0 C. In this hot/cold process, cooling before addition of perfume oil and dye can be omitted.
If the fat phase here is an oil which has low viscosity at room temperature, both phases can be initially introduced and emulsified at a temperature of 20-30 0 C (cold/cold process) (from W. Umbach, "Kosmetik" [Cosmetics], Georg Thieme Verlag, Stuttgart, 1995).
9911777.doc 3/22 -3- In the preparation of emulsions, suspensions and dispersions which are delivered to the end consumer, it is desirable to obtain products which are stable for an extended period, do not tend to separate out and in which at the same time the added active ingredients retain their activity;The stability of mixtures is achieved in conventional products by the addition of additives, such as, for example, emulsifiers, surfactants or the like. In order to prevent decomposition of the contents and to hinder a decrease in the activity of active ingredients present, oxidation stabilisers, freeradical scavengers, bactericides and other additives, for example, are added. Various of these additives may result in irritation or allergies in the case of sensitive users.
In order to stabilise active ingredients, it is in many cases not the active ingredient itself that is used, but instead one of its more stable derivatives, which then decomposes at the site of action and liberates the active ingredient. This is of course afflicted with the problem that the derivative behaves differently to the actual active ingredient in any prior transport or metabolism processes which are necessary.
A further problem in the preparation of the above-mentioned mixtures is homogeneous mixing of the individual substances in each volume element of the mixture as a whole.
r In order to prepare cosmetic formulations, simple stirred vessels with various types of stirrer are frequently used. Depending on the stirrer type (for example anchor, propeller, inclined-blade, disc, EKATO multistage 25 impulse countercurrent stirrers or EKATO Mizer disc), different shear forces occur in the stirred vessels depending on the location in the stirred vessel. The same applies to the temperature distribution and energy input into the formulation, which means that shear forces, temperature and introduced energy are not "uniformly" distributed in the batch vessel, and 30 consequently the build-up of the resultant formulation is adversely affected. In concrete terms, this means that, for example, emulsions may form in which the emulsified phase has very different particle sizes, or the active-ingredient distribution in a prepared product is non-uniform.
The present invention therefore seeks to provide a process which gives mixed products which have a homogeneous distribution of all 9911777.doc 4/22 -4components in the mixture as a whole and at the same time have a homogeneous distribution of the particle or droplet size. A further object of the invention is to provide a process for the preparation of cosmetic or pharmaceutical formulations by means of which the use of emulsifiers, surfactants, stabilisers, oxidation stabilisers, free-radical scavengers, bactericides and other additives can be restricted or by means of which, in the ideal case, their use can be omitted entirely. A further object of the invention is to provide a process by means of which cosmetic or pharmaceutical formulations can be prepared in very small amounts immediately before their use.
This outcome sought by a process for the preparation of cosmetic or pharmaceutical formulations immediately before use, characterised in that two or more liquid components from separate stock chambers are mixed with one another by passing them through a micromixer.
In order to carry out the process according to the invention, two or more components in liquid form, if necessary after warming, from separate stock chambers are passed through a micromixer for mixing.
The mixing can take place by passing the components in liquid form, if necessary after warming, from separate stock chambers through a temperature-controlled micromixer and if necessary continuing stirring for 25 cooling.
The process for the preparation of cosmetic or pharmaceutical formulations in the form of emulsions immediately before use can be carried out by passing one or more liquid component(s) with one or more natural, synthetic or semi-synthetic oil(s) from separate stock chambers through a micromixer, during which they are mixed with one another.
eeoc The invention's desired outcome is also sought by a process for the preparation of cosmetic formulations in the form of emulsions immediately before use, characterised in that a fat phase consisting of one or more natural, synthetic or semi-synthetic oil(s) and one or more fat(s) which is 2001 9911777.doc 5/22 1 (are) solid at room temperature, is liquefied in a stock chamber by warming, and this liquid fat phase is mixed with one or more liquid component(s) and optionally with a further oil phase by passing them through a micromixer.
In a particular embodiment of the process according to the invention, the components to be mixed are pumped from the stock chambers into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer, and is forced through the channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of an emulsion.
It is also possible in accordance with the invention to convey the components to be mixed from pressurised stock chambers through connecting thin tubes, each of which terminates in a channel of a micromixer, to feed the components into the micromixer and to force them through the channels of the micromixer due to the pressure which builds up, with intensive mixing and formation of an emulsion.
The invention's desired outcome is furthermore sought by a process for the preparation of liposome-containing formulations immediately before use by mixing one or more liquid component(s) with a component which contains liposome-forming contents from separate stock chambers with one another by passing them through a micromixer with formation of the desired liposomes. This can be carried out after one or more of the component(s) to be mixed has (have) been warmed before preparation of the formulation.
This process can be carried out by pumping the components to be mixed from the stock chambers and feeding them into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer, and forcing them through the channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome-containing formulation.
In particular, the components to be mixed can be conveyed from 35 pressurised stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer. Owing 2001 9911777.doc 6/22 -6to the pressure prevailing in the stock chambers, an adequate pressure is built up in the micromixer to force the components through the channels with intensive mixing and formation of a liposome-containing formulation.
The present invention is also achieved by means of lotions or solution, emulsions, gels and creams which can be prepared by the process according to the invention.
For certain formulations, uniform mixing, a constant temperature and uniform input of energy even at the micro-level, are important.
It has now been found that the use of micromixers enables the preparation of mixtures in the form of emulsions, suspensions and dispersions, lotions, solutions gels and creams in which all contents are uniformly distributed, even in extremely small volume parts. In contrast to a large-volume stirred reactor, it is possible to prepare these mixtures under uniform temperature conditions, even at the micro-level, since no temperature gradient forms in the thin, optionally laminate-like channels, in particular if the micromixer has a temperature-controllable design. Furthermore, the input of energy is the same in each volume part, i.e. even in the smallest. It has also been found that emulsions having a significantly more homogeneous droplet size distribution can be prepared than in a stirred vessel. Owing to the multiple shear conditions of the communicating channels in the micromixer, droplet sizes in the micro-range are inevitably specified, so that microemulsions are obtained, which could only be prepared in a very complex manner in a stirred vessel. The use of a micromixer is therefore suitable for the preparation of very fine homogeneous formulations.
Suitable for carrying out the process according to the invention are micromixers and associated connection and sealing systems which are described in the patent applications DE 1 95 11 603, DE 1 97 46 583, DE 1 97 46 584, DE 19746585 and DE 1 98 54 096, and modifications thereof that are evident to the person skilled in the art. Suitable micromixers may consist of suitable metallic, ceramic or polymeric materials or of silicon.
Problematic formulations in the W/O area are emulsions, in particular those having high contents of vegetable triglycerides. Emulsions without 2001 9911777.doc 7/22 -7stabilising waxes are frequently distinguished by inadequate long-term viscosity constancy, and O/W lotions are generally more difficult to stabilise than creams. These emulsions can therefore be prepared particularly well using micromixers. It is of particular advantage here than the use of micromixers enables particularly small amounts to be prepared, which can advantageously be prepared in situ, i.e. directly before use.
Microemulsions are thermodynamically stable if, owing to extremely low interfacial energy, they are formed spontaneously, i.e. without the supply of external mechanical energy. The droplet diameters are significantly smaller than in the case of macroemulsions; they are in the range nm (nanometers), i.e. below the wavelength of visible light. Microemulsions are therefore colloidally disperse, optically transparent systems. According to POHLER, certain concentration ranges of the oil and water phases and of the emulsifiers and auxiliaries must be observed for the formulation of microemulsions: Surfactants (usually nonionic surfactants) 15 Mineral oil or vegetable oil 5 Polyalcohols 0- Water 35 The use of micromixers for the preparation of microemulsions enables the use of surfactants to be considerably reduced, enabling the toleration for particularly sensitive skin types to be significantly increased. Stable microemulsions can be prepared using as little as less than 10% by weight of surfactants.
The most important requirements of emulsification equipment are usually adequate and in particular variable emulsification power, sufficient shear or impact forces, fitting-out for uniform treatment of the batch, vacuum device, heating and cooling These problems can be solved in a simple manner in accordance with the invention through the use of a suitable micromixers, which ensure specific input of energy in each 2001 9911777.doc 8/22 -8volume element and in which intensive mixing takes place in the thin channels with exposure to intensive shear forces.
The use of micromixers furthermore enables very small amounts of the desired cosmetic or pharmaceutical formulations to be prepared immediately before use. This has the advantage that the addition of emulsifiers, suspension aids and dispersion aids in the form of surfactants and other additives, such as, for example, stabilisers, can be greatly restricted or their use can be omitted entirely. It is also possible in this way for active ingredients or additives which are incompatible with one another in a formulation over an extended period not to be mixed with one another until directly before use.
Active ingredients which are only stable in a formulation in the form of a derivative can be initially introduced as such in a separate formulation and not added to the remaining mixture until directly before use. This also enables the user to add various additives, as desired, to small amounts of a base mixture at various points in time. This may be of interest both for pharmaceutical and for cosmetic formulations if different active ingredients are to be applied at different points in time.
Different additives can be added to a cosmetic base formulation for the day than for the night. Additives for the day may be, for example, UV filters, while those for the night may be regenerating additives.
For better understanding and for illustration, examples are given below which fall within the scope of protection of the present invention, but are not suitable for restricting the invention to these examples.
Example 1 Hand and nail cream Raw material INCI
WW
A Paraffin Mineral Oil 2.00 (Art. No. 107162) Arlamol HD Isohexadecane 2.00 2001 9911777.doc 9/22 -9- Isopropyl palmitate Soya oil Mirasil DM 350 Lanette O Span 60 Montanov 68 -(a-Bisabolol (Art. No.130170) Isopropyl Palmitate Glycine Soya Dimethicone Cetearyl Alcohol Sorbitan Stearate Cetearyl Alcohol (and) Cetearyl Glucoside Bisabolol Aqua Glycerin Panthenol Biotin 3.00 0.50 1.00 1.00 1.50 4.00 0.30 B Demin. water Glycerin, 87% (1) (Art. No.104091) D-Panthenol (7) (D+)-Biotin (1) (Art. No.130220) (if desired) preservatives to 100 10.00 0.50 0.05 q.s.
C Rhodicare S If desired: D Perfume Bianca Xanthan Gum 0.30 Perfume 0.20 Preparation: Phases A, B and C are each introduced separately into a stock container and heated to 75 0 C. The consequently liquid phases B and C are pumped out of the stock containers and passed through a micromixer held at 75°C and mixed. The mixture emerging from the micromixer is subsequently pumped with phase A through a micromixer held at 75C and homogenised. The resultant emulsion is collected in a stock container and cooled with stirring. At a temperature of about 0 C, the perfume can be added if desired.
Notes: pH 25 oc value: Viscosity: 43000 mPa.s (Brookfield RVT, spindle C, 5 rpm, Helipath) at 25 0
C
0.05% of propyl 4-hydroxybenzoate (Merck KGaA, Art. No. 130173), 2001 9911777.doe 10/22 0. 15% of methyl 4-hydroxybenzoate (Merck KGaA, Art. No. 13 0174), 0.30% of Germall 115 (ISP, Frechen) Procurement sources: Merck KGaA, Darmstadt ICI Surfactants, Essen Henkel KGaA, D~sseldorf Gustav Hees, Stuttgart Rhodia, Frankfurt Seppic, France BASF, Ludwigshafen HandR, Holzminden 2001 9911777.doc 11/22 11 Example 2 W/0 body-care milk (COLD PREPARATION) A. ARLACEL 780 5.0 Paraffin oil, low-viscosity 10.0% Miglyol 812 4.0 ARLAMOL HD 50 ARLAMOL E Perfume (if desired) q.s.
B. Glycerin ATLAS G-2330 Mg S0 4 0.5 Demin. water 70.5 Preservative (if desired) q.s.
Preparation method: The two phases A and B are each introduced separately into a stock container. After mixing, which can be carried out either by stirring or in small vessels by shaking, the phases are pumped out of the stock containers and passed jointly through a micromixer, in which the phases are mixed intensively. The homogeneously mixed milk can be used directly.
Viscosity: 000 mPa s (Brookfield LVT Helipath, spindle C, 6 rpm, 1 min.) Procurement sources: ICI Surfactants Example 3 Sun-protection milk (water in silicone) 2001 9911777.doc 12/22 12- A Eusolex 2292 (Art. No. 5382) DC 1401 DC 3225 C Dow Corning 344 B Eusolex 232 (Art. No. 5372) aminomethane (Art. No. 8386) No. 6400) 2.00 10.00 10.00 10.00 q.s.
2.00 Tris(hydroxymethyl)- 0.88 Sodium chloride (Art.
2.00 Glycerin (Art.-Nr. 4093) 5.00 Preservative (if q.s.
Water, to 100.00 desired.) demineralised Preparation: In order to prepare phase B, tris(hydroxymethyl)aminomethane for neutralisation of Eusolex 232 is dissolved in water in a stock vessel, and Eusolex 232 is added. After complete dissolution, the remaining raw materials of phase B are added. The components of phase A are premixed in a second stock vessel.
In order to prepare the sun-protection milk, the two phases are, for mixing, pumped jointly with the aid of a pump through a micromixer connected via thin connecting tubes.
Notes Viscosity 22,800 mPas (Brookfield RVT, spindle C, 10 rpm) at 25 'C Samples contain the following as preservatives: 0.05% of propyl 4-hydroxybenzoate (Merck Art. No. 7427) 0.17 of methyl 4-hydroxybenzoate, sodium salt (Merck Art. No. 6756) 2001 9911777.doc 13/22 -13- Procurement sources: E. Merck, Darmstadt Dow Corning, Dusseldorf Example 4 Transparent microemulsion Trade name Eumulgin B2 Cetiol RE Uniphen P-23 Mineral oil Glycerin Water, demin..
Preparation: INCI by weight Ceteareth-20 PEG-7 Glyceryl Cocoate Phenoxyethanol Methyl-/ Ethyl-/Propyl-/Butylparaben Mineral Oil Glycerin Water 19.5 20.0 0.3 20.0 35.2 1. Eumulgin B2, Cetiol HE, Uniphen P-23 and the paraffin oil are introduced into a stock vessel, melted with mixing and heated to about 95C-1050C.
2. Water and the glycerin are combined and likewise heated to about 95 0 C-100 0 C. Increase the amount of water by 3%.
3. The water phase and the fat phase are pumped through a micromixer for intensive mixing. The resultant microemulsion gel stirs for cooling.
Alternatively, it is possible to pass the microemulsion gel through a further, cooled micromixer whose exit channels have a broader cross section, thus preventing blockage of the channels and suppressing the formation of air bubbles in the gel.
At a temperature at which the microemulsion gel is still just pourable, it is transferred into the primary packaging.
2001 9911777.doc 14/22 -14- Example Sun-protection gel (emulsifier-free) SPF 3.21 UVA PF 2.5 (sun protection factor, Diffey Method) by weight A Eusolex 2292 (Art. No. 105382) 1.000 Luvitol EHO 9.000 Dow Corning 200 (100 cs) 2.000 Antaron V-220 2.000 Jojoba oil 5.000 DL-a-Tocopherol acetate 0.500 (Art. No. 500952) B Tris(hydroxymethyl)aminomethane 0.700 (Art. No. 108386) Water, demineralised 14.300 C Pemulen TR-1 0.600 Preservative (if desired) q.s.
Water, demineralised to 100. 000 D Aloe Vera Gel 1: 10 1.000 Preparation: For phase C, homogeneously disperse the Pemulen TR-1 in water, add preservative and pre-swell. Introduce phase B into phase C with homogenisation. Dissolve phase A with heating and add slowly with homogenisation. Add phase D at 35°C and again homogenise.
Notes: Viscosity 67,000 mPas (Brookfield RVT, spindle C, 5 rpm) at
PH
25 oc 6.9 As preservative, 1.0% of phenoxyethanol (Merck Art. No. 807291) can be i1 added.
2001 9911777.doc 15/22 Procurement sources (1) (3) (5) (7) Merck KGaA, Darmstadt Dow Corning, Dusseldorf Henry Lamnotte, Bremen Rahn, Maintal BASF, Ludwigshafen GAF, Frechen Goodrich, Neuss Example 6 In situ W/O/Wsuper-moisturising cream Composition:
WIW
'Brij 721 Brij 72 Arlacel P135 Arlamol E Arlamol
HD
Vitamin E acetate Laurex CS Stearic acid Mirasil DM 100 1.2-Propylene glycol Allantoin Urea Water 0.2 74.4 Germaben 111.
2001 9911777.doc 16/22 -16- D. (if desired) Perfume L94-5770 0.1 Preparation: 1. A and B are warmed to a temperature of 75 0 C in separate stock containers.
2. Before the emulsion is prepared, C is added to B.
3. The phases A and B/C are mixed intensively by pumping them through a micromixer held at 75 0
C.
4. The resultant emulsion is collected in a stock vessel.
5. If desired, D is added after cooling to a temperature below 35 0
C.
6. Further cooling to room temperature is carried out with gentle stirring.
Notes: Viscosity 43,000 mPa.s (Brookfield LVT T-bar spindle, E, rpm 6, 1 min.) Example 7 W/ONW face moisturiser (two-step preparation) Composition: Primary emulsion W/O
W/W
A. Arlacel 1MO 3.3 Arlacel 2064 Arlamol HD 15.0 Arlamol' M812 14.0 B Water 63.7 Germaben II 2001 9911777.doc 17/22 -17- Secondary emulsion W/O/W A. Primary emulsion W/O 50.0 B. 'Arlatone 2121 Water 44.1 Keltrol 0.4 C. Germaben II Preparation: Primary emulsion W/O 1. B is slowly added to A with vigorous stirring.
2. The resultant emulsion is homogenised for a further 5 minutes.
Secondary emulsion W/O/W 1. The composition indicated under B with the exception of Keltrol is warmed to a temperature of 80 0 C. Keltrol is dispersed in the initially introduced composition with stirring at constant temperature.
The two separately prepared compositions A and B are mixed in a micromixer as described above.
2. C is added to the emulsion cooled to a temperature below 40 0
C.
25 3. The mixture is cooled to room temperature with gentle stirring..
Notes:: Viscosity 16,000 mPa.s (Brookfield LVT, spindle D, rpm 6, min.) Persons skilled in the art will appreciate that numerous variations and modifications will become apparent. All such variations and modifications which become apparent to persons skilled in the art, should be considered to fall within the spirit and scope that the invention broadly appearing 35 before described.
*o* PAWPDOCS\CRN\Susn\Spc\7631680.doc-02/UI03 -17a- Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or group of integers or steps but not the exclusion of any other integer or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge in Australia.
**o *e

Claims (16)

1. Process for the preparation of cosmetic and/or pharmaceutical formulations immediately before use, characterised in that two or more liquid components from separate stock chambers are mixed with one another by passing them through a communciating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
2. Process for the preparation of cosmetic and/or pharmaceutical formulations, characterised in that, characterised in that two or more components in liquid form, if necessary after warming, from separate stock chambers are passed through a communicating channel within a micromixer for mixing, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
3. Process according to Claims 1 to 2, characterised in that two or more components in liquid form, if necessary after warming, from separate 20 stock chambers are passed through a communicating channel within a temperature-controlled micromixer for mixing, wherein the liquid :components are exposed to multiple shear conditions within the communicating channel of the micromixer and subsequently stirred.
4. Process for the preparation of cosmetic and/or pharmaceutical formulations in the form of emulsions immediately before use, characterised in that one or more liquid component(s) with one or more natural, synthetic or semi-synthetic oil(s) from separate stock chambers are mixed with one another by passing them through a communicating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
Process for the preparation of cosmetic and/or pharmaceutical formulations in the form of emulsions immediately before use, characterised in that a fat phase consisting of one or more natural, P:\WPDOCS\CRNSum\Sp\763 16S0.doc-02/03 -19- solid at room temperature, is liquefied in a stock chamber by warming, and this liquid fat phase is mixed with one or more liquid component(s) and, if desired, with a further oil phase by passing them through a communicating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
6. Process according to Claims 1 to 5, characterised in that the com- ponents to be mixed are pumped from the stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure building up due to the pumping, with intensive mixing and formation of an emulsion.
7. Process according to Claims 1, 4 to 6, characterised in that the com- ponents to be mixed are pumped from the pressurised stock cham- bers, fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of an emulsion.
8. Process for the preparation of liposome-containing formulations immediately before use, characterised in that one or more liquid com- ponent(s) with a component containing liposome-forming contents from separate stock chambers are mixed with one another by passing them through a communicating channel within a micromixer with formation of the desired liposomes, wherein the liquid components 30 are exposed to multiple shear conditions within the communicating channel of the micromixer.
9. Process for the preparation of liposome-containing formulations according to Claim 8, characterised in that one or more of the com- ponent(s) to be mixed is (are) warmed before preparation of the formulation.
P:\WPDOCS\CR Susm\Spm\761680.dc.O02IO1O3 Process according to Claims 8 to 9, characterised in that characterised in that the components to be mixed are pumped from the stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome- containing formulation.
11. Process according to Claims 8 to 10, characterised in that the com- ponents to be mixed are pumped from pressurised stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome-containing formulation.
12. Lotion or solution, prepared by a process according to Claims 1 to 11.
:13. Emulsion, prepared by a process according to Claims 1 to 11.
14. Gel, prepared by a process according to Claims 1 to 11.
15. Cream, prepared by a process according to Claims 1 to 11.
16. Process for the preparation of cosmetic and/or pharmaceutical formulations, and/or the formulations prepared thereby, substantially as hereinbefore described, with reference to the accompanying 30 Examples. DATED this 2nd day of October, 2003 MERCK PATENT GMBH by its Patent Attorneys DAVIES COLLISON CAVE
AU39611/00A 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use Ceased AU768399B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19911777A DE19911777A1 (en) 1999-03-17 1999-03-17 Process for the preparation of cosmetic formulations
DE19911777 1999-03-17
PCT/EP2000/001974 WO2000054735A1 (en) 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use

Publications (2)

Publication Number Publication Date
AU3961100A AU3961100A (en) 2000-10-04
AU768399B2 true AU768399B2 (en) 2003-12-11

Family

ID=7901216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39611/00A Ceased AU768399B2 (en) 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use

Country Status (7)

Country Link
EP (1) EP1161221A1 (en)
JP (1) JP2002538947A (en)
CN (1) CN1344145A (en)
AU (1) AU768399B2 (en)
CA (1) CA2367391A1 (en)
DE (1) DE19911777A1 (en)
WO (1) WO2000054735A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9017623B2 (en) 2007-02-06 2015-04-28 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10357772B2 (en) 2007-04-19 2019-07-23 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10639597B2 (en) 2006-05-11 2020-05-05 Bio-Rad Laboratories, Inc. Microfluidic devices
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10732649B2 (en) 2004-07-02 2020-08-04 The University Of Chicago Microfluidic system
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
ES2436668T3 (en) 2000-12-20 2014-01-03 Covidien Lp Catheter to remove atheromatous or thrombotic occlusive material
DE10100721A1 (en) * 2001-01-10 2002-07-11 Beiersdorf Ag Stable, aqueous UV-protective cosmetic or dermatological preparation, contains benzimidazole-sulfonic acid derivative UV filter, water-soluble preservative and water-soluble or -dispersible dye
DE10208265A1 (en) * 2002-02-26 2003-09-11 Beiersdorf Ag Continuous production of cosmetic and/or dermatological compositions, containing temperature-sensitive components, comprises emulsification, addition of sensitive components and then homogenization
EP1356857B1 (en) * 2002-04-16 2006-06-21 Fuchs Lubritech Gmbh Method for producing and applying of emulsifier free oil-in-water dispersions as a release agent or cooling lubricant
DE10219523A1 (en) * 2002-05-02 2003-11-13 Wella Ag Process for the technical production of hair or skin cosmetic products using equipment with microstructure units
JP2006507921A (en) 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Method and apparatus for fluid dispersion
EP3616781A1 (en) 2003-04-10 2020-03-04 President and Fellows of Harvard College Formation and control of fluidic species
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
DE10333924B3 (en) 2003-07-25 2004-10-07 Wella Ag Packaging system for multicomponent products (e.g. cosmetics or pharmaceuticals) requiring mixing immediately before use, comprises assembly of static micro-mixers
JP2005068125A (en) * 2003-08-21 2005-03-17 Rohm & Haas Co Method for preparing biocide-blended material
JP4025735B2 (en) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー Method for treating aqueous systems
CN104069784B (en) 2003-08-27 2017-01-11 哈佛大学 electronic control of fluidic species
EP1703968A1 (en) * 2003-12-16 2006-09-27 Unilever Plc Microfluidic device
JP2007152280A (en) * 2005-12-07 2007-06-21 Kao Corp Manufacturing method of hydrogel particle, and composite particle manufacturing apparatus used for the same
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
DE102007039005A1 (en) * 2007-08-14 2009-02-19 Beiersdorf Ag Micro-emulsion, useful as transparent/translucent cosmetic product or in transparent/translucent cosmetic product preparation, and to prepare skin/hair care product, comprises emulsifying agent and/or co-emulsifying agent
DE102007039007A1 (en) * 2007-08-14 2009-02-19 Beiersdorf Ag Preparation of transparent or translucent emulsion, useful as cosmetic/in cosmetic preparation, and in skin and hair care product to clean the skin and hair, comprises conducting oil phase comprising silicon and water phase by micro-mixer
DE102007057131A1 (en) 2007-11-26 2009-05-28 Beiersdorf Ag Preparing an emulsion, useful e.g. as sun protection- or make-up-preparation and as repellents to protect against mosquitoes, comprises mixing fat- and water-phase containing a solid material in a micromixer and emulsifying the mixture
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
WO2010045226A2 (en) 2008-10-13 2010-04-22 Fox Hollow Technologies, Inc. Devices and methods for manipulating a catheter shaft
AU2010241801B2 (en) 2009-04-29 2013-04-11 Covidien Lp Methods and devices for cutting and abrading tissue
BRPI1010595A2 (en) 2009-05-14 2017-05-16 Tyco Healthcare easily cleanable atherectomy catheters and methods for use
KR101130932B1 (en) 2009-11-12 2012-03-29 곽영열 Manufacture system for emulsion using an air
EP2506783B1 (en) 2009-12-02 2016-06-29 Covidien LP Methods and devices for cutting tissue
KR101398384B1 (en) 2009-12-11 2014-05-23 코비디엔 엘피 Material removal device having improved material capture efficiency and methods of use
US9119662B2 (en) 2010-06-14 2015-09-01 Covidien Lp Material removal device and method of use
DE102010046931A1 (en) * 2010-09-29 2012-03-29 Sanderstrothmann Gmbh Process for the preparation of a cosmetic product
BR112013009835A2 (en) 2010-10-28 2016-07-26 Covidien Lp material removal device and method of use
KR20150020240A (en) 2010-11-11 2015-02-25 코비디엔 엘피 Flexible debulking catheters with imaging and methods of use and manufacture
WO2013033426A2 (en) 2011-09-01 2013-03-07 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9579157B2 (en) 2012-09-13 2017-02-28 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
EP2875803A1 (en) * 2013-11-26 2015-05-27 OTC GmbH Polyol-in-oil-emulsions for dermal delivery
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
FR3039396B1 (en) * 2015-07-28 2017-08-11 Laboratoires M&L BASE OF CONCENTRATED COSMETIC FORMULATION
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
JP7039575B2 (en) 2016-09-30 2022-03-22 アモーレパシフィック コーポレーション Cosmetic composition preparation device containing an instantly emulsified emulsion based on a microfluidic channel
KR102371209B1 (en) 2017-03-24 2022-03-07 (주)아모레퍼시픽 Apparatus for manufacturing cosmetic using instantaneous emulsification and maufacturing method of cosmetic using instantaneous emulsification
CN115770273A (en) * 2022-10-10 2023-03-10 重庆大学附属肿瘤医院 A topical Chinese medicinal liniment, and its preparation method and equipment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769321A (en) * 1979-10-03 1988-09-06 Self Colin H Assay method and reagent therefor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405489A (en) * 1981-01-15 1983-09-20 Carter-Wallace, Inc. Production of a post-foaming gel and system therefor
DE3230289A1 (en) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen PRODUCTION OF PHARMACEUTICAL OR COSMETIC DISPERSIONS
CA1257545A (en) * 1985-05-23 1989-07-18 Hans A. Schaeffer Dental composition, method of preparation thereof and container therefor
US5593508A (en) * 1991-02-11 1997-01-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Moist, absorbent material for cleaning articles and surfaces
EP0564672B2 (en) * 1992-04-06 1999-05-06 Baxter International Inc. Aqueous solution for peritoneal dialysis
CA2165209A1 (en) * 1994-04-20 1995-11-02 Yoshitomi Pharmaceutical Industries Ltd. Container filled with infusion liquids, infusion preparation and high calorie infusion preparation comprising vitamins
EP0729746A1 (en) * 1995-02-28 1996-09-04 Unilever Plc Vitamin C delivery system
DE19511603A1 (en) * 1995-03-30 1996-10-02 Norbert Dr Ing Schwesinger Device for mixing small amounts of liquid
JP2975943B2 (en) * 1996-02-20 1999-11-10 農林水産省食品総合研究所長 Emulsion manufacturing method and emulsion manufacturing apparatus
DE19611270A1 (en) * 1996-03-22 1997-09-25 Gesim Ges Fuer Silizium Mikros Micro-mixer for very small volumes of liquids or suspensions
DE19746585A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Coupling for micro components with parallel plates
DE19746583A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Micro-mixer for liquid, viscous or gaseous phases
DE19746584A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Micro-mixer housing
DE19854096A1 (en) * 1998-11-24 2000-05-25 Merck Patent Gmbh Connection carrier for plate shaped micro-components, comprises at least one carrier rail fixed to a carrier plate, with a slot for a micro-component insert edge.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769321A (en) * 1979-10-03 1988-09-06 Self Colin H Assay method and reagent therefor

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US10732649B2 (en) 2004-07-02 2020-08-04 The University Of Chicago Microfluidic system
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9410151B2 (en) 2006-01-11 2016-08-09 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9534216B2 (en) 2006-01-11 2017-01-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US10639597B2 (en) 2006-05-11 2020-05-05 Bio-Rad Laboratories, Inc. Microfluidic devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US10603662B2 (en) 2007-02-06 2020-03-31 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US9017623B2 (en) 2007-02-06 2015-04-28 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US10960397B2 (en) 2007-04-19 2021-03-30 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10675626B2 (en) 2007-04-19 2020-06-09 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10357772B2 (en) 2007-04-19 2019-07-23 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10808279B2 (en) 2010-02-12 2020-10-20 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11965877B2 (en) 2011-02-18 2024-04-23 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions

Also Published As

Publication number Publication date
CA2367391A1 (en) 2000-09-21
WO2000054735A1 (en) 2000-09-21
CN1344145A (en) 2002-04-10
DE19911777A1 (en) 2000-09-21
EP1161221A1 (en) 2001-12-12
AU3961100A (en) 2000-10-04
JP2002538947A (en) 2002-11-19

Similar Documents

Publication Publication Date Title
AU768399B2 (en) Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
AU760488B2 (en) Packaging system for cosmetic formulations
JP5755694B2 (en) Microcapsule filled with active ingredient and method for producing the same
EP2509565B1 (en) Emulsifier-free, polymer-stabilised foam formulations
KR101472304B1 (en) A stable nano-emulsion with narrow particle size distribution
EP1702607A1 (en) Monophase microemulsion composition, o/w ultrafine emulsion external formulation and process for producing the same
US5296166A (en) Method of manufacturing emulsions
CN1845720B (en) Concentrated and diluted stable oil/water emulsions
JP2003321325A (en) Process for commercially manufacturing hair or skin cosmetic product using apparatus having micro structural unit
EP1656121B1 (en) Biliquid foams, stable dispersions thereof and a corresponding process of manufacturing
WO2017030409A1 (en) Blue emulsion composition containing lecithin and sodium dilauramidoglutamide lysine
JP4318265B2 (en) Multi-component packaging with static micromixer
CN1937990B (en) Polyaphron dispersions containing complex internal phase
JP2009263346A (en) Emulsion-type cosmetic containing kinetin
CN102264462A (en) Use of copolymers based on polyethers and vinyl monomers as stabilizing agents for emulsions
JPS63126542A (en) Microemulsion
KR102337010B1 (en) Semi-transparent oil-in-water cosmetic composition with high content of oil stabilized, and preparing method for the same
CN1938387A (en) Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations
KR20200049150A (en) Oil-in-water type cosmetic composition with a low viscosity comprising a high content of oil
Patil et al. AN OVERVIEW ON NANOEMULSION: A NOVEL DRUG DELIVERY SYSTEM
Sankari et al. Nanoemulsions-approaching thermodynamic stability
EP4003301A1 (en) Continuous method for nano-emulsification by concentration phase inversion
JP2003238351A (en) Capsule-containing skin care composition

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)